Stasinos Chr. Sikalias · The science of compounding

Lidocaine hydrochloride 2% w/v oromucosal topical solution

CGR-BR-015 · ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

Historical source editionCGR-BR-015Brazil

HISTORICAL SOURCE EDITION — compare with the current edition before use.

Dosage formOromucosal preparation
Reference batch100 mL
Monograph version4.0
Source packagev4

Source formula

IngredientSource quantity
Lidocaine hydrochloride2 g
Sodium saccharin0.1 g
FNFB paraben concentrate2.5 g
Purified waterq.s. ad 100 mL

Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.

Description

Partial evidence

Oromucosal preparation: Lidocaine hydrochloride 2% w/v oromucosal topical solution. Additional appearance criteria are not established by the specific text reviewed.

References: [1]

Use and action

Documented in source

Topical anaesthesia of oral mucosa.

References: [1]

Specifications

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Light

Partial evidence

Protect lidocaine hydrochloride from light.
For the finished product the source specifies:
Well-closed opaque plastic or amber glass, protected from light, room temperature.

References: [1] · [2]

Air

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Water and solubility

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Humidity

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Temperature

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

pH and related incompatibilities

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Other incompatibilities

Partial evidence

Lidocaine HCl adsorption to PVC depends on pH/temperature; assess the specific container material.

References: [2]

Ingredient-specific information

Partial evidence

Lidocaine hydrochloride: Protect lidocaine hydrochloride from light.
These are selected facts for identified ingredients; relevant sensitivities and incompatibilities are detailed in the corresponding fields. This is not a complete SDS for every material.

References: [2]

Personal protective equipment

Partial evidence

Complete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.

References: [1] · [3]

Risks and precautions

Partial evidence

A complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.

References: [1]

Compounding conditions

Partial evidence

Follow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.

References: [1]

BUD rationale

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.

References: [1]

Bases and dependencies

Documented in source

Paraben concentrate 6% + 3% w/w → CGR-BR-001

References: [1]

Equipment

Editorial checklist

Indicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials, Suitable filtration medium. Selection/qualification is defined locally.

References: [1]

Preparation procedure

Documented in source

Dissolve lidocaine hydrochloride and saccharin in water. Add preservative, make to volume, mix and filter.

References: [1]

Observations

Documented in source

Topical oromucosal use; do not swallow. Not an injection. Historical source dosing is not reproduced.

References: [1]

Packaging

Documented in source

Well-closed opaque plastic or amber glass, protected from light, room temperature.

References: [1]

Quality control

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Storage

Documented in source

Well-closed opaque plastic or amber glass, protected from light, room temperature.

References: [1]

Dispensing and directions

Documented in source

Do not swallow. In children, use only on medical advice with adult supervision.

References: [1]

Labelling

editorial_specimen

Lidocaine hydrochloride 2% w/v oromucosal topical solution
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Στοματοβλεννογόνια χρήση / Oromucosal use
Dose/directions: __________
Storage: Well-closed opaque plastic or amber glass, protected from light, room temperature.
Do not swallow. In children, use only on medical advice with adult supervision.

References: [1]

Sources and traceability

  1. ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

    2012, 2nd ed., Rev. 02 — superseded · PDF pp. 98 · A2

    Review date reported in supplied metadata: 2026-09-10

  2. FN/2003/PA/020 LIDOCAÍNA, HIDROCLORURO DE

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1

    Review date reported in supplied metadata: 2026-09-10

  3. PN/L/PG/002/00 INDUMENTARIA

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1

    Review date reported in supplied metadata: 2026-09-10

Provenance and reuse

This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.

SHA-256 of the supplied PDF: 6f4f1c826f4e975289bd1b71091578a4021a0bd1eb495622d577fafe5b7f04e6